LNTH

Dopo l'orario di chiusura: 79.49

Lantheus Holdings Inc (LNTH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché LNTH Giù? Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Lantheus Holdings Inc Stock (LNTH) Company Profile

Lantheus Holdings Inc

Healthcare (1116)

978 671-8001

331 TREBLE COVE ROAD, NORTH BILLERICA, MA

Prossima data di guadagno

Ultimi documenti SEC

LNTH's Discussions on Twitter

Compare LNTH vs TAK, ZTS, HLN, TEVA, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LNTH Lantheus Holdings Inc	79.49	5.14B	1.54B	233.56M	348.64M	3.3669
TAK Takeda Pharmaceutical Co Adr	17.77	56.14B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	115.62	48.81B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	10.03	44.67B	14.54B	2.22B	2.58B	0.4879
TEVA Teva Pharmaceutical Industries Ltd Adr	28.57	33.27B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	536.12	23.50B	3.18B	1.33B	1.04B	27.90

Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-26	Aggiornamento	William Blair	Mkt Perform → Outperform
2025-12-12	Aggiornamento	Truist	Hold → Buy
2025-10-08	Downgrade	Goldman	Buy → Neutral
2025-08-12	Downgrade	Truist	Buy → Hold
2024-12-18	Iniziato	Goldman	Buy
2024-09-03	Iniziato	Redburn Atlantic	Buy
2024-07-10	Reiterato	JMP Securities	Mkt Outperform
2023-12-18	Downgrade	William Blair	Outperform → Mkt Perform
2023-12-04	Iniziato	TD Cowen	Outperform
2023-09-29	Iniziato	William Blair	Outperform
2023-03-08	Iniziato	JMP Securities	Mkt Outperform
2022-11-30	Iniziato	SVB Leerink	Outperform
2022-10-13	Iniziato	Mizuho	Buy
2022-05-09	Iniziato	B. Riley Securities	Buy
2022-04-13	Iniziato	Truist	Buy
2021-02-01	Iniziato	SVB Leerink	Outperform
2020-06-29	Ripresa	Jefferies	Buy
2019-08-16	Aggiornamento	CJS Securities	Market Perform → Market Outperform
2017-11-02	Aggiornamento	Wells Fargo	Market Perform → Outperform
2016-11-08	Reiterato	RBC Capital Mkts	Outperform
2016-09-23	Ripresa	Credit Suisse	Neutral
2016-02-24	Reiterato	RBC Capital Mkts	Outperform
2015-12-11	Downgrade	Credit Suisse	Outperform → Neutral
2015-09-30	Downgrade	Wells Fargo	Outperform → Market Perform
2015-07-20	Iniziato	Credit Suisse	Outperform
2015-07-20	Iniziato	Jefferies	Buy
2015-07-20	Iniziato	RBC Capital Mkts	Outperform
2015-07-20	Iniziato	Robert W. Baird	Outperform
2015-07-20	Iniziato	Wells Fargo	Outperform

Mostra tutto

Lantheus Holdings Inc Borsa (LNTH) Ultime notizie

Lantheus Holdings Inc Azioni (LNTH) Dati Finanziari

Lantheus Holdings Inc (LNTH)

Lantheus Holdings Inc Stock (LNTH) Company Profile

Compare LNTH vs TAK, ZTS, HLN, TEVA, UTHR

Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades

Lantheus Holdings Inc Borsa (LNTH) Ultime notizie

FDA approves Lantheus’ PYLARIFY TruVu for prostate cancer imaging - Investing.com Nigeria

Lantheus Secures Two FDA Milestones in Four Days: Lutathera Radioequivalent and PSMA PET Upgrade - Oncodaily

Lantheus Holdings (LNTH) Is Up 5.4% After New PYLARIFY TruVu And LUTATHERA ApprovalsHas The Bull Case Changed? - simplywall.st

Why Lantheus (LNTH) Is Up 5.4% After Dual FDA Wins In Radiopharmaceutical Oncology Expansion - Yahoo Finance

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lantheus Holdings, Inc. (LNTH) And Encourages Stockholders to Connect - ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lantheus Holdings, Inc. (LNTH) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Lantheus Stock Analysis: 57% Gain Amid Revenue and Margin ConcernsNews and Statistics - IndexBox

Imaging & Diagnostics Stocks Decline After Q4 2025 EarningsNews and Statistics - IndexBox

Q4 Earnings Highlights: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & SuppliesImaging, Diagnostics Stocks - Yahoo Finance

WINTON GROUP Ltd Grows Position in Lantheus Holdings, Inc. $LNTH - MarketBeat

Lantheus at Leerink Conference: Strategic Shifts and Challenges - Investing.com Nigeria

Why Lantheus Holdings stock popped by almost 12% last month - MSN

Why Lantheus Holdings Stock Popped by Almost 12% Last Month - AOL.com

Lantheus Holdings Inc (LNTH) Stock Price Up 7.21% on Mar 9 - GuruFocus

Lantheus (NASDAQ:LNTH) Trading 7.2% HigherTime to Buy? - MarketBeat

Citizens reiterates Lantheus stock rating on royalty opportunities By Investing.com - Investing.com Canada

Why Is LNTH Stock Up After Hours? - Stocktwits

(LNTH) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lantheus Holdings, Inc. (LNTH) And Encourages Investors to Reach Out - ACCESS Newswire

Lantheus drops as Truist downgrades after Q2 miss - MSN

2026-03-08 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lantheus Holdings, Inc. (LNTH) And Encourages Investors to Reach Out | NDAQ:LNTH | Press Release - Stockhouse

FDA approves Lantheus’ PYLARIFY TruVu for prostate cancer imaging By Investing.com - Investing.com Australia

Lantheus Holdings Q1 2025 Earnings Preview - MSN

Teachers Retirement System of The State of Kentucky Reduces Stake in Lantheus Holdings, Inc. $LNTH - MarketBeat

Wall Street Zen Upgrades Lantheus (NASDAQ:LNTH) to Strong-Buy - MarketBeat

American Century Companies Inc. Sells 341,642 Shares of Lantheus Holdings, Inc. $LNTH - MarketBeat

Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection - Sahm

TD Cowen updates financial model citing upcoming Q4 results for Lantheus Holdings, Inc. (LNTH) - MSN

Lantheus (LNTH) Gains FDA Approval for New Prostate Cancer Imagi - GuruFocus

Lantheus Announces FDA Approval of PYLARIFY TruVu (piflufolastat F 18) Injection - Finviz

Lantheus Announces FDA Approval of PYLARIFY TruVu™, a New Formulation of Its PSMA PET Imaging Agent to Enhance Patient Access and Supply Capacity - Quiver Quantitative

Lantheus announces FDA approval of Pylarify TruVu (piflufolastat F 18) injection - marketscreener.com

US FDA approves Lantheus' new prostate cancer imaging formulation - Reuters

FDA OKs new PYLARIFY TruVu scan to expand prostate cancer imaging - Stock Titan

Heron Bay Capital Management Acquires New Shares in Lantheus Holdings, Inc. $LNTH - MarketBeat

Elo Mutual Pension Insurance Co Acquires New Stake in Lantheus Holdings, Inc. $LNTH - MarketBeat

Lantheus Bets On TruVu To Keep PYLARIFY Growing - Finimize

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lantheus Holdings, Inc. (LNTH) And Encourages Stockholders to Reach Out - ACCESS Newswire

Quantbot Technologies LP Makes New Investment in Lantheus Holdings, Inc. $LNTH - MarketBeat

Equity award, tax share disposition for Lantheus (LNTH) officer - Stock Titan

Lantheus (NASDAQ: LNTH) CCO logs PSU vesting, tax withholding - Stock Titan

Lantheus Holdings (LNTH) CFO nets PSU award, withholds shares for taxes - Stock Titan

LNTH Stock Price, Quote & Chart | LANTHEUS HOLDINGS INC (NASDAQ:LNTH) - ChartMill

William Blair Investment Management LLC Has $29.48 Million Stake in Lantheus Holdings, Inc. $LNTH - MarketBeat

Intech Investment Management LLC Sells 33,704 Shares of Lantheus Holdings, Inc. $LNTH - MarketBeat

Lantheus receives FDA tentative approval for generic cancer drug By Investing.com - Investing.com Canada

Lantheus Holdings (LNTH): Analyst Raises Price Target to $89 | L - GuruFocus

Lantheus (LNTH) Secures FDA Tentative Nod for New Cancer Treatme - GuruFocus

Lantheus Says US FDA Tentatively Approves PNT2003 - marketscreener.com

Lantheus receives FDA tentative approval for generic cancer drug - Investing.com India

Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA® - The Manila Times

Lantheus Holdings Inc Azioni (LNTH) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a LNTH